NO992062L - Preparat for behandling av astma, inneholdende loratadin og et dekongestionsmiddel - Google Patents

Preparat for behandling av astma, inneholdende loratadin og et dekongestionsmiddel

Info

Publication number
NO992062L
NO992062L NO992062A NO992062A NO992062L NO 992062 L NO992062 L NO 992062L NO 992062 A NO992062 A NO 992062A NO 992062 A NO992062 A NO 992062A NO 992062 L NO992062 L NO 992062L
Authority
NO
Norway
Prior art keywords
asthma
decongestant
preparation
treatment
containing loratadine
Prior art date
Application number
NO992062A
Other languages
English (en)
Norwegian (no)
Other versions
NO992062D0 (no
Inventor
Alan G Harris
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of NO992062L publication Critical patent/NO992062L/no
Publication of NO992062D0 publication Critical patent/NO992062D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO992062A 1996-10-31 1999-04-29 Preparat for behandling av astma, inneholdende loratadin og et dekongestionsmiddel NO992062D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73966996A 1996-10-31 1996-10-31
PCT/US1997/019158 WO1998018470A1 (en) 1996-10-31 1997-10-29 Composition, for the treatment of asthma, containing loratadine and a decongestant

Publications (2)

Publication Number Publication Date
NO992062L true NO992062L (no) 1999-04-29
NO992062D0 NO992062D0 (no) 1999-04-29

Family

ID=24973307

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992062A NO992062D0 (no) 1996-10-31 1999-04-29 Preparat for behandling av astma, inneholdende loratadin og et dekongestionsmiddel

Country Status (21)

Country Link
EP (1) EP0941091A1 (xx)
JP (1) JP2000505104A (xx)
KR (1) KR20000052922A (xx)
CN (1) CN1235545A (xx)
AR (1) AR008908A1 (xx)
AU (1) AU731756B2 (xx)
BR (1) BR9712705A (xx)
CA (1) CA2268546A1 (xx)
CO (1) CO4910128A1 (xx)
CZ (1) CZ150999A3 (xx)
HU (1) HUP9904075A3 (xx)
ID (1) ID23431A (xx)
IL (1) IL129662A0 (xx)
NO (1) NO992062D0 (xx)
NZ (1) NZ335078A (xx)
PE (1) PE11399A1 (xx)
PL (1) PL333056A1 (xx)
SK (1) SK54599A3 (xx)
TR (1) TR199901003T2 (xx)
WO (1) WO1998018470A1 (xx)
ZA (1) ZA979731B (xx)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6270796B1 (en) * 1997-10-29 2001-08-07 Robert E. Weinstein Antihistamine/decongestant regimens for treating rhinitis
US6132758A (en) 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
IT1303671B1 (it) * 1998-07-28 2001-02-23 Nicox Sa Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio
AU6018899A (en) * 1998-09-10 2000-04-03 Schering Corporation Antihistamines for treating non-infective sinusitis or otitis media
US6521254B2 (en) 1998-12-07 2003-02-18 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis
WO2000050015A1 (en) * 1999-02-23 2000-08-31 Yuhan Corporation Pharmaceutical capsule compositions containing loratadine and pseudoephedrine
KR100505899B1 (ko) * 1999-02-23 2005-08-01 주식회사유한양행 로라타딘과 슈도에페드린을 함유한 캅셀제 조성물
WO2000057880A1 (en) * 1999-03-29 2000-10-05 Schering Corporation Methods and compositions for treating allergic and related disorders using fluorinated descarboethoxyloratadine
AU2276801A (en) * 1999-12-20 2001-07-03 Schering Corporation Extended release oral dosage composition
SK287684B6 (sk) * 1999-12-20 2011-06-06 Schering Corporation Pevná orálna farmaceutická dávková forma s predĺženým uvoľňovaním
AU4248400A (en) * 2000-04-14 2001-10-30 J Med Pharmaceuticals Inc Single-dose antihistamine/decongestant formulations for treating rhinitis
AU2001264806A1 (en) * 2000-05-25 2001-12-03 Schering Corporation Stable liquid and solid formulations
BR0210534A (pt) * 2001-06-20 2004-06-22 Schering Corp Anti-histaminas para o tratamento de congestão nasal e obstrução nasal
NZ588134A (en) 2005-06-17 2010-11-26 Aft Pharmaceuticals Ltd Novel pharmaceutical for use in a method for treatment of upper respiratory mucosal congestion
NZ573174A (en) * 2006-06-01 2012-01-12 Msd Consumer Care Inc Sustained release pharmaceutical dosage form containing phenylephrine
TWI411451B (zh) * 2006-06-01 2013-10-11 Msd Consumer Care Inc 用於結腸吸收之脫羥腎上腺素醫藥調配物及組合物
KR101540191B1 (ko) * 2014-02-24 2015-07-28 성균관대학교산학협력단 로라타딘을 포함하는 항염증용 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1110397A (en) * 1964-10-02 1968-04-18 Mead Johnson & Co Ephedrine composition
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
US5314697A (en) * 1992-10-23 1994-05-24 Schering Corporation Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
US5595997A (en) * 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine

Also Published As

Publication number Publication date
AR008908A1 (es) 2000-02-23
CZ150999A3 (cs) 1999-10-13
WO1998018470A1 (en) 1998-05-07
HUP9904075A3 (en) 2002-02-28
CO4910128A1 (es) 2000-04-24
BR9712705A (pt) 1999-10-26
PL333056A1 (en) 1999-11-08
AU731756B2 (en) 2001-04-05
EP0941091A1 (en) 1999-09-15
TR199901003T2 (xx) 1999-07-21
HUP9904075A2 (hu) 2000-05-28
JP2000505104A (ja) 2000-04-25
NO992062D0 (no) 1999-04-29
PE11399A1 (es) 1999-02-09
CA2268546A1 (en) 1998-05-07
SK54599A3 (en) 2000-08-14
ZA979731B (en) 1998-04-29
KR20000052922A (ko) 2000-08-25
IL129662A0 (en) 2000-02-29
CN1235545A (zh) 1999-11-17
NZ335078A (en) 2000-10-27
ID23431A (id) 2000-04-20
AU4995397A (en) 1998-05-22

Similar Documents

Publication Publication Date Title
NO992062L (no) Preparat for behandling av astma, inneholdende loratadin og et dekongestionsmiddel
NO985464L (no) Konsentrert antistoffpreparat
NO972475L (no) Ny antitrombotisk formulering, fremgangsmåte for dens fremstilling og anvendelse derav
IS2788B (is) Búdesóníð- / formóterólefnablanda til innöndunar með lausa þéttni frá 0,30 til 0,36 g/ml, aðferð við að framleiða efnablönduna og notkun hennar
NO983641L (no) Fremgangsmåte til behandling og farmasöytisk preparat
NO972780D0 (no) Inhalasjonsanordning, fremgangsmåte for fordeling av et farmasöytisk aktivt stoff og fremgangsmåte for administrering av en dose med et farmasöytisk aktivt stoff
SE9600071D0 (sv) New oral formulation of two active ingredients I
TW329387B (en) Pharmaceutical composition for treating airway passage and lung diseases comprising mometasone furoate
NO20010844L (no) Regulering av substrataktivitet
NO20040968L (no) Opioidagonistpreparater med frigjorbar og sekvestrert antagonist
NO993847L (no) FremgangsmÕter og preparater for behandling av allergisk astma og andre sykdommer ved anvendelse av deskarboetoksyloratadin
EE04800B1 (et) Oraalne manustamisvorm happes ebapüsiva toimeainetarbeks, toimeaineühik, selle valmistamismeetod ja kasutamine ning meetod oraalse manustamisvormi valmistamiseks
AU2002224914A1 (en) Method and device for the diagnosis and therapy of chronic heart failure
NO308854B1 (no) Terapeutiske forbindelser, farmasøytisk akseptable salter og formuleringer inneholdende forbindelsene, samt anvendelser derav
NO20015931L (no) Farmasöytiske formuleringer og fremgangsmåter som omfatter intranasal morfin
DE60128912D1 (en) Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika
ITRM920412A1 (it) Eteroprostanoidi, procedimento per la loro preparazione e loro impiego terapeutico.
WO1998020869A3 (en) Formulation for electrically assisted delivery of lidocaine and epinephrine
BR0213293A (pt) Uso de tfpi ou de um análogo de tfpi no tratamento de septicemia
SE9603725D0 (sv) New teatment
NO20101070L (no) Fremgangsmate til dosering av et medikament, samt doseringsform
NO20000293L (no) Preparater, kits og fremgangsmõter for inhibering av cerebrale neurovaskulære forstyrrelser og muskulære hodepiner
NO943288L (no) Anvendelse av pentoksyfyllin ved fremstilling av farmasöytiske preparater til behandling av granulomatöse og fibroserende lungesykdommer
SE9902597D0 (sv) New use
NO20052313L (no) Vandig farmasoytisk formulering omfattende trombininhibitorer melagatran og anvendelse av formuleringen for fremstilling av et medikament for anvendelse i nasal administrering i behandling av

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application